Prospective cohort Study of Adaptive servo-ventilation therapy on prognosis In repeatedly hospitalized patients with chronic heart failure: Longitudinal observational study of effects on re-admission and mortality

Prospective cohort Study of Adaptive servo-ventilation therapy on prognosis In repeatedly hospitalized patients with chronic heart failure: Longitudinal observational study of effects on re-admission and mortality - SAVIOR-L

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034295

Enrollment

1100

Registered

2018-09-29

Start date

2019-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Subjects who have been hospitalized at least once due to heart failure within the previous t 1 year from the presentl admission. (2)Subjects who can regularly visit medical institutions as outpatients after the discharge. (3)Subjects who can visit the hospital a year after the discharge. (4)Subjects aged 20 and over at the time of obtaining informed consent. (5)Subjects who have fully understand the study participation and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Subjects unable to make an independent judgment about participation in the study. (2)Subjects diagnosed with dementia (3)Subjects who have been already registered with this study (4)Subjects currently participating in other clinical trials (5)Subjects in inappropriate condition for the trial judged by investigators

Design outcomes

Primary

Measure	Time frame
The length of time between the date of the baseline and the date of death / admission to the hospital from any cause.	—

Secondary

Measure	Time frame
The length of time between the date of discharge and the date of cardiac events. The length of time between the date of discharge and the start date of the first non-drug therapy for cardiac events or exacerbation of heart failure. Number of hospitalized days for a year from the date of discharge. Number of hospitalizations for a year from the date of discharge. The level of improvement of QOL Clinical composite response The rate of improvement of natriuretic peptide	—

Measure

Time frame

The length of time between the date of discharge and the date of cardiac events. The length of time between the date of discharge and the start date of the first non-drug therapy for cardiac events or exacerbation of heart failure. Number of hospitalized days for a year from the date of discharge. Number of hospitalizations for a year from the date of discharge. The level of improvement of QOL Clinical composite response The rate of improvement of natriuretic peptide

—

Countries

Japan

Contacts

Public ContactYuka Nakajima

Public Health Research Foundation (PHRF) Comprehensive Support Project for Clinical Research of Lifestyle-Related Disease (CSP-LD)

savior@csp.or.jp03-5287-2639

Outcome results